Discover
OM
Outset Medical, Inc.
5.10
2 x 3.64
2 x 5.63
bid
ask
+
0.78
18.06%
2 @ 04:00 PM
5.03 -0.07 (1.37%)
| Ytd | 37.47% | |
| 1y | -75.40% |
4.40
day range
5.15
3.00
52 week range
21.36
| Open | 4.40 | Prev Close | 4.32 | Low | 4.40 | High | 5.15 | Mkt Cap | 94.54M |
| Vol | 318.75K | Avg Vol | 213.28K | EPS | -2.74 | P/E | N/A | Forward P/E | -0.89 |
| Beta | 1.95 | Short Ratio | 2.94 | Inst. Own | 52.16% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 4.42 | 200-d Avg | 6.24 | 1yr Est | 4.00 |
Earning
| Date | For | Estimate | Reported | Surprise | surprise % |
|---|---|---|---|---|---|
| 2024-11-06 | 2024-09 | -0.42 | -0.39 | 0.03 | 7.14% |
| 2024-08-07 | 2024-06 | -0.43 | -0.47 | -0.04 | -9.30% |
| 2024-08-07 | 2024-06 | -0.43 | N/A | N/A | N/A |
| 2024-05-08 | 2024-03 | -0.53 | -0.57 | -0.04 | -7.55% |
| 2024-05-08 | 2024-03 | -0.53 | N/A | N/A | N/A |
| 2024-02-21 | 2023-12 | -0.61 | N/A | N/A | N/A |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| 2024-08-08 | RBC Capital | Downgrade | Outperform | Sector Perform |
| 2024-08-08 | TD Cowen | Upgrade | Buy | Buy |
| 2024-06-21 | RBC Capital | Upgrade | Sector Perform | Outperform |
| 2024-04-08 | BTIG | Upgrade | Buy | |
| 2024-01-12 | RBC Capital | Downgrade | Outperform | Sector Perform |
| 2023-12-04 | Morgan Stanley | Upgrade | Equal-Weight | Equal-Weight |
Profile
Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
Insider Holder
| Date | Name | Relation | Quantity | Description |
|---|---|---|---|---|
| 2024-11-14 | AHMED NABEEL | Chief Financial Officer | 310.77K | Sale |
| 2024-11-14 | BROTTEM JOHN L. | General Counsel | 227.09K | Sale |
| 2024-05-28 | DREXLER KAREN | Director | 48.23K | Stock Award(Grant) |
| 2024-06-02 | GROSSMAN DONALD KEITH | Director | 79.22K | Conversion of Exercise of derivative security |
| 2024-05-28 | HACKETT PATRICK T. | Director | 42.85K | Stock Award(Grant) |
| 2024-05-28 | HINRICHS JAMES F | Director | 80.35K | Stock Award(Grant) |
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | FMR, LLC | 4.77M | 5.63M | 9.09% |
| 2024-09-29 | Vanguard Group Inc | 2.64M | 3.12M | 5.03% |
| 2024-09-29 | Millennium Management Llc | 1.89M | 2.23M | 3.59% |
| 2024-09-29 | Ameriprise Financial, Inc. | 1.81M | 2.14M | 3.45% |
| 2024-09-29 | GMT Capital Corp | 1.47M | 1.74M | 2.80% |
| 2024-09-29 | Mubadala Investment Co PJSC | 1.44M | 1.70M | 2.74% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-10-30 | Fidelity Select Portfolios - Medical Technology & Devices Port | 3.30M | 3.89M | 6.28% |
| 2024-09-29 | Vanguard Total Stock Market Index Fund | 1.65M | 1.94M | 3.14% |
| 2024-09-29 | Vanguard Extended Market Index Fund | 753.84K | 889.53K | 1.43% |
| 2024-10-30 | Fidelity Extended Market Index Fund | 293.31K | 346.11K | 0.56% |
| 2024-08-30 | Schwab Strategic Tr-Schwab U.S. Small Cap ETF | 238.41K | 281.32K | 0.45% |
| 2024-09-29 | Morgan Stanley Inst Fund Inc-Inception Port | 196.18K | 231.50K | 0.37% |
Split
| Split | Date |
|---|---|
| 1 : 15 | 2025-03-20 |